Cancer-fighting biotech startup Indapta lands $30M with assist from FDA

The company, which has dual headquarters in Seattle and Houston, triggered a tranche of funding by gaining FDA clearance to begin phase 1 trials for its cell therapy aimed at cancer.
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news